DHS Data Privacy and Integrity Advisory Committee; Meeting, 60510-60511 [2011-25079]
Download as PDF
<![CDATA[
60510
Federal Register / Vol. 76, No. 189 / Thursday, September 29, 2011 / Notices
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘Combined Multipurpose
Prevention Strategies for Sexual and
Reproductive Health’’.
Date: October 18, 2011.
Time: 12:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Jane K. Battles, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, Room 3147, Bethesda, MD
20892–7616, 301–451–2744,
battlesja@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘Combined Multipurpose
Prevention Strategies for Sexual and
Reproductive Health’’.
Date: October 31, 2011.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Jane K. Battles, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, Room 3147, Bethesda, MD
20892–7616, 301–451–2744,
battlesja@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 23, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–25096 Filed 9–28–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSKG8SOYB1PROD with NOTICES
National Institutes of Health
Prospective Grant of Exclusive
License: Compositions and Method for
Preventing Reactogenicity Associated
with Administration of Immunogenic
Live Rotavirus Compositions
National Institutes of Health,
Public Health Service, HHS.
AGENCY:
VerDate Mar<15>2010
15:29 Sep 28, 2011
Jkt 223001
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health, Department of
Health and Human Services, is
contemplating the grant of an exclusive
patent license to practice the inventions
embodied in U.S. Provisional Patent
Application No. 60/178,689, filed
January 28, 2000 [HHS Ref. No. E–088–
2000/0–US–01], now expired; PCT
Patent Application No. PCT/US01/
02686 [HHS Ref. No. E–088–2000/0–
PCT–02] filed January 26, 2001, which
published as WO/2001/54718 on August
2, 2001, now expired; U.S. Patent No.
7,431,931 [HHS Ref. No. E–088–2000/0–
US–06]; Australian Patent No. 784344
[HHS Ref. No. E–088–2000/0–AU–04];
German Patent No. 60141681.308 [HHS
Ref. No. E–088–2000/0–DE–08]; French
Patent No. 1251869 [HHS Ref. No. E–
088–2000/0–FR–09]; United Kingdom
Patent No. 1251869 [HHS Ref. No. E–
088–2000/0–GB–10]; and Canadian
Patent Application No. 2398428 [HHS
Ref. No. E–088–2000/0–CA–05], entitled
‘‘Compositions and Method for
Preventing Reactogenicity Associated
with Administration of Immunogenic
Live Rotavirus Compositions,’’ and all
continuing applications to International
Medica Foundation, having a place of
business in Rochester, Minnesota. The
patent rights in these inventions have
been assigned to the United States of
America.
The prospective exclusive license
territory may be ‘‘worldwide’’, and the
field of use may be limited to ‘‘rhesusbased rotavirus therapeutic and/or
prophylactic vaccines.’’
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
October 31, 2011 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to: Kevin W. Chang, Ph.D.,
Senior Licensing and Patenting
Manager, Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Telephone:
(301) 435–5018; Facsimile: (301) 402–
0220; E-mail: changke@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
present invention provides
compositions for making a medicament
and methods for the administration of
vaccine compositions for protection
against human rotaviral disease without
significant reactogenicity. Human x
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
rhesus reassortant rotavirus
compositions were made which when
administered during the first 7 to about
10 days of life, provided a composition
which was non-reactogenic followed by
booster immunizations at 16 to 18
weeks or 14 to 20 weeks, up to 1 year
of age. The immune response induced
by the initial neonatal administration of
the live rotavirus vaccine composition
protects the infant from the
reactogenicity of the composition when
administered as a second vaccine dose
at or after 2 months of age.
Administration of the immunogenic
composition also is expected to ablate or
significantly diminish the increase in
the excess of intussusception observed 3
to 7 days following administration of
the initial dose of rotavirus vaccine at
about 2 to 4 months.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within thirty (30) days from the date of
this published notice, the NIH receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: September 22, 2011.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2011–25098 Filed 9–28–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2011–0076]
DHS Data Privacy and Integrity
Advisory Committee; Meeting
Privacy Office, DHS.
Notice.
AGENCY:
ACTION:
On Wednesday, September
21, 2011, the DHS Privacy Office
announced in the Federal Register at 76
FR 58524 that the Data Privacy and
SUMMARY:
E:\FR\FM\29SEN1.SGM
29SEN1
Federal Register / Vol. 76, No. 189 / Thursday, September 29, 2011 / Notices
Integrity Advisory Committee would
meet on October 5, 2011, in Arlington,
Virginia. This notice supplements that
original meeting notice.
Dated: September 23, 2011.
Mary Ellen Callahan,
Chief Privacy Officer, Department of
Homeland Security.
The DHS Data Privacy and
Integrity Advisory Committee will meet
on Wednesday, October 5, 2011, from 1
p.m. to 5 p.m. Please note that the
meeting may end early if the Committee
has completed its business.
[FR Doc. 2011–25079 Filed 9–28–11; 8:45 am]
DATES:
Notice of
this meeting is given under the Federal
Advisory Committee Act, 5 U.S.C. App.,
which requires that notices of meetings
of advisory committees be announced in
the Federal Register 15 days prior to the
meeting date. A notice of the meeting of
the Board was published in the Federal
Register on September 21, 2011, 14 days
prior to the meeting, due to the
mistaken delivery of the notice to
another Federal agency rather than to
the Federal Register. The other Federal
agency received the notice, and the
Federal Register office received that
agency’s material. By the time the error
was noted by each office and DHS was
contacted, DHS could no longer meet
the 15 day requirement. During the
meeting the Committee will discuss
draft guidance to the Department on
privacy protections for information
sharing within DHS. The draft guidance
will be posted on the Committee’s web
site (https://www.dhs.gov/privacy) in
advance of the meeting. If you wish to
submit comments on the draft guidance,
you may do so in advance of the
meeting by forwarding them to the
Committee at the locations listed under
ADDRESSES in the original notice. Please
include the Docket Number (DHS 2011–
0076) in your comments. A public
comment period will be held during the
meeting from 4 p.m. to 4:30 p.m., and
speakers are requested to limit their
comments to 3 minutes. If you would
like to address the Committee at the
meeting, we request that you register in
advance by contacting Martha K.
Landesberg at the address listed under
ADDRESSES in the original notice or sign
up at the registration desk on the day of
the meeting.
SUPPLEMENTARY INFORMATION:
tkelley on DSKG8SOYB1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Martha K. Landesberg, Executive
Director, DHS Data Privacy and Integrity
Advisory Committee, Department of
Homeland Security, Washington, DC
20528, by telephone (703) 235–0780, by
fax (703) 235–0442, or by e-mail to
PrivacyCommittee@dhs.gov.
VerDate Mar<15>2010
15:29 Sep 28, 2011
Jkt 223001
BILLING CODE 9110–9L–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2011–0662]
Amendment of Marine Safety Manual,
Volume III
Coast Guard, DHS.
Notice of proposed policy
change and request for comments.
AGENCY:
ACTION:
The Coast Guard is
considering cancelling its policy
concerning the issuance of Merchant
Mariner Credentials endorsed as Able
Seaman-Mobile Offshore Units. The
policy is currently found in Chapter 16
of the Marine Safety Manual, Volume
III. The Coast Guard will accept
comments from the public on whether
to cancel the policy and on any impacts
the cancellation may have.
DATES: Comments and related material
must either be submitted to our online
docket via https://www.regulations.gov
on or before October 31, 2011 or reach
the Docket Management Facility by that
date.
ADDRESSES: You may submit comments
identified by docket number USCG–
2011–0662 using any one of the
following methods:
(1) Federal eRulemaking Portal:
https://www.regulations.gov.
(2) Fax: 202–493–2251.
(3) Mail: Docket Management Facility
(M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001.
(4) Hand delivery: Same as mail
address above, between 9 a.m. and
5 p.m., Monday through Friday, except
Federal holidays. The telephone number
is 202–366–9329.
To avoid duplication, please use only
one of these four methods. See the
‘‘Public Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section
below for instructions on submitting
comments.
SUMMARY:
If
you have questions about this notice,
call or e-mail Luke B. Harden, Mariner
Credentialing Program Policy Division
(CG–5434), U.S. Coast Guard, telephone
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
60511
202–372–2357, e-mail
CG5434@uscg.mil. If you have questions
on viewing material in the docket, call
Renee V. Wright, Program Manager,
Docket Operations, telephone 202–366–
9826.
SUPPLEMENTARY INFORMATION:
Public Participation
You may submit comments and
related material regarding whether to
cancel the Able Seaman-Mobile
Offshore Units (AB–MOU) endorsement.
All comments received will be posted,
without change, to https://
www.regulations.gov and will include
any personal information you have
provided.
Submitting comments: If you submit a
comment, please include the docket
number for this notice (USCG–2011–
0662) and provide a reason for each
suggestion or recommendation. You
may submit your comments and
material online or by fax, mail or hand
delivery, but please use only one of
these means. We recommend that you
include your name and a mailing
address, an e-mail address, or a
telephone number in the body of your
document so that we can contact you if
we have questions regarding your
submission.
To submit your comment online, go to
https://www.regulations.gov and click on
the ‘‘submit a comment’’ box, which
will then become highlighted in blue. In
the ‘‘Document Type’’ drop down menu,
select ‘‘Notices’’ and insert ‘‘USCG–
2011–0662’’ in the ‘‘Keyword’’ box.
Click ‘‘Search,’’ and then click on the
balloon shape in the ‘‘Actions’’ column.
If you submit your comments by mail or
hand delivery, submit them in an
unbound format, no larger than 81⁄2; by
11 inches, suitable for copying and
electronic filing. If you submit
comments by mail and would like to
know that they reached the Facility,
please enclose a stamped, self-addressed
postcard or envelope.
We will consider all comments and
material received during the comment
period.
Viewing the comments: To view the
comments, go to https://
www.regulations.gov and click on the
‘‘Read Comments’’ box, which will then
become highlighted in blue. In the
‘‘Keyword’’ box, insert ‘‘USCG–2011–
0662’’ and click ‘‘Search.’’ Click the
‘‘Open Docket Folder’’ in the ‘‘Actions’’
column. If you do not have access to the
internet, you may view the docket
online by visiting the Docket
Management Facility in Room W12–140
on the ground floor of the Department
of Transportation West Building, 1200
New Jersey Avenue, SE., Washington,
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 76, Number 189 (Thursday, September 29, 2011)]
[Notices]
[Pages 60510-60511]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25079]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
Office of the Secretary
[Docket No. DHS-2011-0076]
DHS Data Privacy and Integrity Advisory Committee; Meeting
AGENCY: Privacy Office, DHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: On Wednesday, September 21, 2011, the DHS Privacy Office
announced in the Federal Register at 76 FR 58524 that the Data Privacy
and
[[Page 60511]]
Integrity Advisory Committee would meet on October 5, 2011, in
Arlington, Virginia. This notice supplements that original meeting
notice.
DATES: The DHS Data Privacy and Integrity Advisory Committee will meet
on Wednesday, October 5, 2011, from 1 p.m. to 5 p.m. Please note that
the meeting may end early if the Committee has completed its business.
SUPPLEMENTARY INFORMATION: Notice of this meeting is given under the
Federal Advisory Committee Act, 5 U.S.C. App., which requires that
notices of meetings of advisory committees be announced in the Federal
Register 15 days prior to the meeting date. A notice of the meeting of
the Board was published in the Federal Register on September 21, 2011,
14 days prior to the meeting, due to the mistaken delivery of the
notice to another Federal agency rather than to the Federal Register.
The other Federal agency received the notice, and the Federal Register
office received that agency's material. By the time the error was noted
by each office and DHS was contacted, DHS could no longer meet the 15
day requirement. During the meeting the Committee will discuss draft
guidance to the Department on privacy protections for information
sharing within DHS. The draft guidance will be posted on the
Committee's web site (https://www.dhs.gov/privacy) in advance of the
meeting. If you wish to submit comments on the draft guidance, you may
do so in advance of the meeting by forwarding them to the Committee at
the locations listed under ADDRESSES in the original notice. Please
include the Docket Number (DHS 2011-0076) in your comments. A public
comment period will be held during the meeting from 4 p.m. to 4:30
p.m., and speakers are requested to limit their comments to 3 minutes.
If you would like to address the Committee at the meeting, we request
that you register in advance by contacting Martha K. Landesberg at the
address listed under ADDRESSES in the original notice or sign up at the
registration desk on the day of the meeting.
FOR FURTHER INFORMATION CONTACT: Martha K. Landesberg, Executive
Director, DHS Data Privacy and Integrity Advisory Committee, Department
of Homeland Security, Washington, DC 20528, by telephone (703) 235-
0780, by fax (703) 235-0442, or by e-mail to PrivacyCommittee@dhs.gov.
Dated: September 23, 2011.
Mary Ellen Callahan,
Chief Privacy Officer, Department of Homeland Security.
[FR Doc. 2011-25079 Filed 9-28-11; 8:45 am]
BILLING CODE 9110-9L-P
